
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.
Investor Presentation Deck
Tetra Investor Presentation
– Strengthens Company’s portfolio with the manufacturers of leading high-quality, crafted cannabis edibles and extracts – Continues to establish itself as a vertically integrated operator with the latest acquisition announcement – Gains access in close […]
Based on strong results in its pre-clinical animal study, CytoDyn files for Orphan Drug Designation for Triple-Negative Breast Cancer VANCOUVER, Washington, Feb 20, 2019 – CytoDyn Inc. (otc.qb:CYDY), a biotechnology company developing a novel humanized […]
DENVER, Sept. 16, 2019 — Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man Technologies” or the “Company”) announced a culmination of its roll-up strategy today that would solidify the Company as one of the largest vertically integrated cannabis […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.